S. Ghalandari
1, Sh. Zolala
1 
, S. Dadshahi
2* 1 "Nursing Research Center" and ” Razi Faculty of Nursing and Midwifery", Kerman University of Medical Sciences, Kerman, Iran
2 "Nursing Research Center”, “Counselling in Midwifery Department, Razi Faculty of Nursing and Midwifery", Kerman University of Medical Sciences, Kerman, Iran
Abstract
Aims: Polycystic ovarian syndrome is a highly prevalent disorder. The worldwide prevalence of polycystic ovarian syndrome ranges from 4% to 21%. Depression and anxiety are more common and more severe in women with polycystic ovarian syndrome than in women without the disorder. This study aimed to systematically review the literature for polycystic ovarian syndrome.
Information & Methods: A systematic search of EMBASE, Cochrane, PubMed, CINAHL, Google Scholar, Scopus, and International Pharmaceutical Abstracts from inception until January 2019 utilizing the terms polycystic ovarian syndrome was conducted.
Findings: Polycystic ovarian syndrome and insulin resistance share a common genetic background. Metabolic dysfunction can exist among people even when controlling for BMI and body fat distribution. Obesity is common in women with polycystic ovarian syndrome and exacerbates metabolic stress. Infertility was noted by 72% of women reporting polycystic ovarian syndrome. Depression and anxiety are more common and more severe in women with polycystic ovarian syndrome. Cardiovascular disease markers point to a higher risk of Cardiovascular disease in women with polycystic ovarian syndrome. Obstructive sleep apnea is common in clinical samples of women with polycystic ovarian syndrome.
Conclusion: A complication of polycystic ovary syndrome is insulin resistance, metabolic dysfunction, obesity, Infertility, cardiovascular disease, obstructive sleep apnea, Depression, and anxiety.